Hypophosphatasia (HPP) is a serious and potentially fatal, systemic, congenital metabolic disease caused by impaired activity of the enzyme alkaline phosphatase (ALP). The systemic consequences of the disease result from changed bone metabolism that often affects the skeleton and/or teeth. Symptoms can also be neurological, respiratory, muscle-related, rheumatological and/or kidney-related.

Hypophosphatasia is a heterogeneous disease and the various forms of the disease can vary a great deal in severity. Mortality is high for the most severe forms in children with symptoms already at the foetal stage and before the age of 6 months. Individuals with the least severe form of hypophosphatasia may not be diagnosed until they reach adulthood.

Leung EC et al. JIMD Rep 2013; 11: 73-78.
Mornet E. Best Pract Res Clin Rheum 2008; 22: 113-127.
Mornet E et al. Ann Hum Genet 2011; 75: 439-445.
Rockman-Greenberg C. Ped Endocrinol Rev 2013; 10 (Suppl 2): 380-388. 
Whyte MP. Ann N Y Acad Sci 2010; 1192: 190-200.

SYMPTOMS AND CONDITIONS
ASSOCIATED WITH HYPOPHOSPHATASIA

COMMON SYMPTOMS AND CONDITIONS THAT
CAN BE CAUSED BY HYPOPHOSPHATASIA READ MORE

THE ALP CALCULATOR
– DIAGNOSTIC TOOL

LOW ALP ACTIVITY KEY TO DIAGNOSIS READ MORE


IMPORTANT DIFFERENTIAL DIAGNOSES

IMPORTANT DIFFERENTIAL 
DIAGNOSES/CONDITIONS READ MORE
AlexionAlexion Pharma Nordics AB, Vasagatan 7, 111 20 Stockholm, Sweden. Copyright © 2017, Alexion Pharmaceuticals, Inc. All rights reserved. Sitemap